ifrik: nice article on herbicide-resistant superweeds, RoundupReady GM crops and #Monsanto 's patent on mixing herbicides

[img_assist|nid=143|title=|desc=|link=none|align=right|width=100|height=43]In zunehmenden Maße werden wissenschafltiche Erkenntnisse und Technologien patentiert, aber WissenschaftlerInnen wird in der Regel zugestanden für ihre eigene Forschung patentierte Substanzen, Technologien und Gensequenzen zu gebrauchen. In anderen Fällen regeln Material Transfer Agreemtnes den Zugang zu intellektuellem oder technischem Eigentum.

A. Lorch, Koryphäe, März 2002.

[img_assist|nid=191|title=|desc=|link=none|align=right|width=100|height=43]In November 2001, the Biotechnology and Development Monitor facilitated an online debate on biotechnology and food production. In the first round, participants were able to determine the discussion agenda. The issues they considered to be the most relevant were patenting, systems of food production, capacity building, and rights and choices. The discussion showed the potential of this kind of online event. It resulted in a report and recommendations for Dutch policies.

L. Asveld & A. Lorch, Biotechnology and Development Monitor December 2001.

[img_assist|nid=178|title=|desc=|link=none|align=right|width=100|height=43]In many countries population pressure, natural disasters, and changing climate conditions demand an urgent solution to the problem of food security. Genetic engineering claims to offer promising solutions, but is this a technology that can be applied with trust – and if so, under what conditions?

Biotechnology and Development Monitor, November 2001.

[img_assist|nid=362|title=|desc=|link=none|align=right|width=100|height=43]With the sequencing of the entire human genome coming closer by the day, the implications resulting from the exploitation of this information are becoming clearer. Intellectual property claims play an important role in the race between private and public sequencing efforts. While pharmaceutical companies are eager to use the generated knowledge to optimize drug development strategies, these will most likely neglect the intrests of developing countries.

V. Lehmann & A. Lorch, Biotechnology and Development Monitor December 1999.